EMEA-001439-PIP01-13-M03

Table of contents

Key facts

Invented name
Exviera
Active substance
Dasabuvir (sodium monohydrate)
Therapeutic area
Infectious diseases
Decision number
P/0289/2020
PIP number
EMEA-001439-PIP01-13-M03
Pharmaceutical form(s)
  • Tablet
  • Age-appropriate oral solid form
Condition(s) / indication(s)
Treatment of chronic hepatitis C
Route(s) of administration
Oral use
Contact for public enquiries
AbbVie Ltd

AbbVie Ltd
E-mail: paediatricsteam@abbvie.com
Tel: +44 7341101902

Decision type
PM: decision on the application for modification of an agreed PIP

Decision

Related content

How useful was this page?

Add your rating